Nirosha M. Lederer, PhD, MSPH
Adjunct Assistant Professor
Dr. Lederer is a policy expert, and health outcomes/economics researcher, and business leader with a proven track record of developing innovative strategies to advance value-based healthcare decision-making by both domestic and international agencies including CMS, FDA, state health agencies, commercial payers, HTAs, guideline developers, and patients. With over 15 years of policy, political, and research experience from across the healthcare ecosystem including at FDA, biopharmaceutical industry, consulting, academia, and Capitol Hill, she has a deep understanding of the challenges facing our healthcare system today. As a distinguished and sought-after public speaker, Dr. Lederer specializes in analyzing intricate healthcare trends, articulating the role of evidence in determining the pricing and reimbursement of medical products, and designing innovative patient-centered access medical product models (e.g., outcomes-based contracts for transformative therapies). Dr. Lederer strives to achieve a high-quality, affordable, accessible, and equitable healthcare system. Bibliography